<DOC>
	<DOCNO>NCT00110838</DOCNO>
	<brief_summary>The objective SOFA trial investigate whether supplemental intake n-3 polyunsaturated fatty acid ( n-3 PUFA ) fish oil reduce recurrence life-threatening ventricular arrhythmia patient implantable cardioverter defibrillator ( ICD ) .</brief_summary>
	<brief_title>SOFA : Study Omega-3 Fatty Acids Ventricular Arrhythmia</brief_title>
	<detailed_description>Previous human observational study clinical trial provide strong indication n-3 PUFA fish prevent cardiovascular disease . Striking study show strong relation n-3 PUFA sudden death , n-3 PUFA non-fatal heart disease . Sudden death one common often first manifestation coronary heart disease . The majority sudden death directly cause acute ventricular arrhythmia . Our hypothesis n-3 PUFA prevents sudden death suppress life-threatening cardiac arrhythmia . Therefore , investigate randomize controlled clinical trial whether supplemental intake n-3 PUFA fish reduce incidence life-threatening cardiac arrhythmia . Our population consist patient implantable cardioverter defibrillator ( ICD ) , device record arrhythmic event memory chip . As ICD enable continuous monitor event nonhospitalised patient , population suitable test possible antiarrhythmic effect n-3 PUFA . The objective SOFA trial investigate effect fish oil incidence recurrent ventricular arrhythmia patient ICD . The SOFA randomise , parallel , placebo-controlled , double-blind intervention study currently carry 26 cardiology center Europe . Five hundred forty six patient ICD randomise receive either 2g/d fish oil placebo oil period 12 month . The primary outcome spontaneous ventricular tachyarrhythmias detect ICD all-cause mortality within 12 month .</detailed_description>
	<criteria>ICD capable record ECG strip least 10 ( attempt ) therapeutic intervention 18 year old write informed consent Primary prophylactic indication ICD implantation ‘ bridge ’ heart transplantation Refractory supraventricular arrhythmia rapid ventricular rate despite antiarrhythmic therapy project lifespan less 1 year participation another trial ( within 30 day SOFA ) use supplemental n3 fatty acid last 3 month intake 8g n3 fatty acid fish per month judge fish frequency questionnaire pregnant woman woman childbearing potential use adequate contraception patient know history recent drug alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2005</verification_date>
	<keyword>fish oil</keyword>
	<keyword>n-3 fatty acid</keyword>
	<keyword>n-3 PUFA</keyword>
	<keyword>omega-3 fatty acid</keyword>
	<keyword>arrhythmia</keyword>
	<keyword>ICD</keyword>
	<keyword>human</keyword>
	<keyword>Patients implantable cardioverter defibrillator</keyword>
</DOC>